Impact of Neoadjuvant Chemohormonal Therapy With GnRH Antagonist and Low‐Dose Estramustine in Very High‐Risk Prostate Cancer Undergoing Robotic Radical Prostatectomy
In patients with very high-risk PC undergoing robot-assisted laparoscopic prostatectomy, a GnRH antagonist and low-dose EMP yielded better BCR-free survival outcomes than NHT.
Authors
- Toshinari Yamasaki
- Yoichiro Tohi (ORCID: https://orcid.org/0000-0003-3884-8915)
- Hiromitsu Negoro (ORCID: https://orcid.org/0000-0003-1144-2755)
- Mutsushi Kawakita (ORCID: https://orcid.org/0009-0003-2494-0355)
- Masashi Kubota (ORCID: https://orcid.org/0000-0002-6978-6932)
- Kimihiro Shimatani (ORCID: https://orcid.org/0000-0002-4611-5706)
- Shiori Murata (ORCID: https://orcid.org/0000-0001-5791-6624)
- Ryoma Kurahashi (ORCID: https://orcid.org/0000-0001-6972-8065)
- Ryoichi Saito (ORCID: https://orcid.org/0000-0002-3163-8723)
- Yuya Sekine
- Takashi Kobayashi (ORCID: https://orcid.org/0000-0002-7240-4851)
- Yuto Hattori
- Atsuro Sawada (ORCID: https://orcid.org/0000-0003-4833-1709)
- Takanari Kambe (ORCID: https://orcid.org/0000-0002-2913-7364)
- Takayuki Goto (ORCID: https://orcid.org/0000-0001-6537-3068)
Institutions
- University of Miyazaki (JP)
- University of Tsukuba (JP)
- Kagawa University (JP)
- Akita University (JP)
- Kyoto University (JP)
- Kobe City Medical Center General Hospital (JP)
- Hyogo University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2025-02-19
- DOI
- https://doi.org/10.1002/pros.24875
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52